Penumbra Inc
(STU:0P8)
€
242.6
2.7 (1.13%)
Market Cap: 9.57 Bil
Enterprise Value: 9.50 Bil
PE Ratio: 299.78
PB Ratio: 8.96
GF Score: 88/100 Penumbra Inc at Goldman Sachs Global Healthcare Conference Transcript
Jun 11, 2019 / 09:00PM GMT
Chris Cooper
Goldman Sachs Group Inc., Research Division - Research Analyst
Okay. Good. I think in the interest of time we'll make a start. Welcome, again, to day 1 of the Goldman Sachs Global Healthcare Conference. My name is Chris Cooper. I'm a health care analyst here at Goldman Sachs. It gives me a great pleasure to introduce Penumbra. So look, I don't know if you guys want to start with maybe just an introductory line or 2 or we can just go straight into it.
Adam Elsesser
Penumbra, Inc. - Co Founder, Chairman, CEO & President
Why don't we get straight into it?
Questions & Answers
Chris Cooper
Goldman Sachs Group Inc., Research Division - Research Analyst
Sure. Absolutely. So look, I mean, maybe we can just make a start on product portfolio. I know you've launched a couple of new products with JET 7 last year. Can you just give us an update on how that's going, please?
Adam Elsesser
Penumbra, Inc. - Co Founder, Chairman, CEO & President
So just
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot